Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor Mansberger et al1 have written an interesting article comparing telemedicine with traditional examinations for usefulness in diabetic retinopathy screening. Their results indicate telemedicine screenings are cost-effective and baseline levels of diabetic retinopathy remain constant over time. It is notable that the authors do not emphasize 2 issues that may have bearing on the usefulness of telemedicine studies.
Orellana J. Teleretinal Screening for Diabetic Retinopathy. JAMA Ophthalmol. 2015;133(10):1221–1222. doi:10.1001/jamaophthalmol.2015.2872